Literature DB >> 32905955

MRI for Rectal Cancer Primary Staging and Restaging After Neoadjuvant Chemoradiation Therapy: How to Do It During Daily Clinical Practice.

Roberta Cianci1, Giulia Cristel2, Andrea Agostini3, Roberta Ambrosini4, Linda Calistri5, Giuseppe Petralia6, Stefano Colagrande7.   

Abstract

PURPOSE: To provide a practical overview regarding the state-of-the-art of the magnetic resonance imaging (MRI) protocol for rectal cancer imaging and interpretation during primary staging and restaging after neoadjuvant chemoradiation therapy (CRT), pointing out technical skills and findings that radiologists should consider for their reports during everyday clinical activity.
METHOD: Both 1.5T and 3.0T scanners can be used for rectal cancer evaluation, using pelvic phased array external coils. The standard MR protocol includes T2-weighted imaging of the pelvis, high-resolution T2-weighted sequences focused on the tumor and diffusion-weighted imaging (DWI). The mnemonic DISTANCE is helpful for the interpretation of MR images: DIS, for distance from the inferior part of the tumor to the anorectal-junction; T, for T staging; A, for anal sphincter complex status; N, for nodal staging; C, for circumferential resection margin status; and E, for extramural venous invasion.
RESULTS: Primary staging with MRI is a cornerstone in the preoperative workup of patients with rectal cancer, because it provides clue information for decisions on the administration of CRT and surgical treatment. Restaging after CRT is crucial for treatment planning, and findings on post-CRT MRI correlate with the patient's prognosis and survival. It may be useful to remember the mnemonic word "DISTANCE" to check and describe all the relevant MRI findings necessary for an accurate radiological definition of tumor stage and response to CRT.
CONCLUSIONS: "DISTANCE" assessment for rectal cancer staging and treatment response estimation after CRT may be helpful as a checklist for a structured reporting.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Post-CRT evaluation; Rectal cancer; Staging

Mesh:

Year:  2020        PMID: 32905955     DOI: 10.1016/j.ejrad.2020.109238

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

1.  Clinical effects of prophylactic transverse colostomy in patients undergoing completely laparoscopic transabdominal approach partial intersphincteric resection.

Authors:  Honghong Zheng; Zhehong Li; Rui Su; Jianjun Li; Shuai Zheng; Ji Yang; Enhong Zhao
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

2.  Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.

Authors:  Giuditta Chiloiro; Davide Cusumano; Paola de Franco; Jacopo Lenkowicz; Luca Boldrini; Davide Carano; Brunella Barbaro; Barbara Corvari; Nicola Dinapoli; Martina Giraffa; Elisa Meldolesi; Riccardo Manfredi; Vincenzo Valentini; Maria Antonietta Gambacorta
Journal:  Radiol Med       Date:  2021-11-01       Impact factor: 3.469

3.  Diffusion-Weighted Magnetic Resonance Imaging of 103 Patients with Rectal Adenocarcinoma Identifies the Apparent Diffusion Coefficient as an Imaging Marker for Tumor Invasion and Regional Lymph Node Involvement.

Authors:  Jaromir Kargol; Wojciech Rudnicki; Jakub Kenig; Justyna Filipowska; Ewa Kaznowska; Tomasz Kluz; Wiesław Guz; Elżbieta Łuczyńska
Journal:  Med Sci Monit       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.